v3.26.1
Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Cash flows from operating activities:    
Net loss $ (7,788) $ (4,334)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 1,843 2,081
Amortization of loan costs and discounts 1,188 607
Loss on extinguishment of debt 2,044 0
(Gain) loss on interest rate hedge (82) 128
Loss on sale of real estate 1,115 0
Equity based payment 801 654
Change in fair value of Earn-Out Liability (0) (370)
Changes in operating assets and liabilities    
Due to/from related parties 0 3
Accounts payable and accrued expenses (1,050) (682)
Other assets (403) 355
Accounts receivable, net 772 28
Net cash used in operating activities (1,560) (1,530)
Cash flows from investing activities:    
Capital expenditures (33) (189)
Proceeds from note receivable 0 3,120
Proceeds from sale of investment in real estate 15,368 0
Net cash provided by investing activities 15,335 2,931
Cash flows from financing activities:    
Proceeds from Line of Credit 0 1,453
Proceeds from notes payable 27 0
Payments on notes payable (8,905) (675)
Payment of debt prepayment costs (2,044) 0
Distributions to non-controlling interest holders (46) (47)
Loan fees (1,986) 0
Share repurchase plan (1,437) (265)
Shares repurchased for vesting of employee awards (145) (113)
Preferred redemption payments (132) (1,149)
Preferred dividend payments (202) (273)
Net cash used in financing activities (14,870) (1,069)
Net change in cash and cash equivalents and restricted cash (1,095) 332
Cash and cash equivalents and restricted cash, beginning of period 15,284 15,819
Cash and cash equivalents and restricted cash, end of period 14,189 16,151
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 8,349 10,655
Restricted cash at beginning of period 6,935 5,164
Cash and cash equivalents and restricted cash, beginning of period 15,284 15,819
Cash and cash equivalents at end of period 8,503 11,617
Restricted cash at end of period 5,686 4,534
Cash and cash equivalents and restricted cash, end of period 14,189 16,151
Supplemental disclosures of cash flow information:    
Interest Paid 2,916 2,847
Non-cash investing and financing activities:    
Distributions declared not yet paid 67 88
Requested preferred redemptions not yet paid 100 826
Accrued capital expenditures $ 96 $ 0

Source